Attached files

file filename
EX-31 - CERTIFICATION - LESCARDEN INClcar_ex31.htm
EX-32 - CERTIFICATION - LESCARDEN INClcar_ex32.htm


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

———————

FORM 10-Q

———————


ü

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

 

 ACT OF 1934

For the quarterly period ended: February 28, 2011

or

 

 

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

 

 ACT OF 1934

For the transition period from: _____________ to _____________


Commission File Number: 0-10035

———————

LESCARDEN, INC.

(Exact name of registrant as specified in its charter)

———————


New York

13-2538207

(State or other jurisdiction

(I.R.S. Employer

of incorporation or organization)

Identification No.)

420 Lexington Ave. Ste 212, New York 10170

(Address of Principal Executive Office) (Zip Code)

(212) 687-1050

(Registrant’s telephone number, including area code)

———————

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was

required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

ü

 Yes

 

 No

 

 

 

 

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any,
every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit

and post such files).

 

 Yes

 

 No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer,
or a smaller reporting company.

 

 

Large accelerated filer

 

 

 

Accelerated filer

 

 

Non-accelerated filer

 

 (Do not check if a smaller

 

Smaller reporting company

ü

 

 

 

 reporting company)

 

 

 

 

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

 

 Yes

ü

 No

 

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class

 

Outstanding April 12, 2011

Common Stock $.001 par value

 

40,076,783

 

 

 




TABLE OF CONTENTS


Page

PART I – FINANCIAL INFORMATION

Item 1.         Financial Statements.

1


Item 2.         Management’s Discussion and Analysis of Financial Condition and Results of Operations.

4


Item 3.         Quantitative and Qualitative Disclosures About Market Risk.

5


Item 4.         Controls and Procedures.

5


PART II – OTHER INFORMATION


Item 1.         Legal Proceedings.

6


Item 1A.      Risk Factors.

6


Item 2.         Unregistered Sales of Equity Securities and Use of Proceeds.

6


Item 3.         Defaults Upon Senior Securities.

6


Item 4.         Removed and Reserved.

6


Item 5.         Other Information.

6


Item 6.         Exhibits.

6

 






PART I - FINANCIAL INFORMATION


Item 1.         Financial Statements.

LESCARDEN INC.

CONDENSED BALANCE SHEETS


 

 

February 28,
2011

 

May 31,
2010

 

 

 

(UNAUDITED)

 

(AUDITED)

 

ASSETS

     

 

 

     

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

84,631

 

$

137,928

 

Accounts receivable

 

 

10,030

 

 

5,321

 

Prepaid expenses

 

 

 

 

6,800

 

Inventory

 

 

112,486

 

 

76,824

 

Total current assets

 

 

207,147

 

 

226,873

 

Deferred income tax asset, net of valuation allowance of
$1,480,000 and $1,464,000 at February 28, 2011 and
May 31, 2010

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

207,147

 

$

226,873

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

201,504

 

$

174,844

 

Shareholder loan

 

 

36,000

 

 

274,000

 

Deferred revenue

 

 

4,075

 

 

33,134

 

Deferred license fees

 

 

24,000

 

 

28,500

 

Total liabilities

 

 

265,579

 

 

510,478

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders' deficit

 

 

 

 

 

 

 

Convertible preferred stock - $.02 par value, authorized 2,000,000 shares, issued and outstanding 92,000 shares

 

 

1,840

 

 

1,840

 

Common stock - $.001 par value, authorized 200,000,000 shares, issued and outstanding 40,076,783 and 30,943,450 shares respectively

 

 

40,077

 

 

30,943

 

Additional paid-in capital

 

 

16,882,481

 

 

16,617,615

 

Accumulated deficit

 

 

(16,982,830

)

 

(16,934,003

)

Stockholders' deficit

 

 

(58,432

)

 

(283,605

)

Total liabilities and stockholders' deficit

 

$

207,147

 

$

226,873

 


See notes to financial statements




1



LESCARDEN INC.

CONDENSED STATEMENTS OF OPERATIONS


 

 

(UNAUDITED)

For the three months

Ended February 28,

 

(UNAUDITED)

For the nine months

Ended February 28,

 

 

 

2011

 

2010

 

2011

 

2010

 

Revenues:

     

 

 

     

 

 

     

 

 

     

 

 

 

Product sales

 

$

 129,251

 

$

 321,174

 

$

448,095

 

$

426,754

 

License fees

 

 

1,500

 

 

27,701

 

 

4,500

 

 

83,103

 

Total revenues

 

 

130,751

 

 

348,875

 

 

452,595

 

 

509,857

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

 

41,705

 

 

95,483

 

 

150,396

 

 

142,120

 

Salaries

 

 

41,559

 

 

27,719

 

 

86,107

 

 

68,386

 

Professional fees and consulting

 

 

25,253

 

 

30,559

 

 

110,286

 

 

116,242

 

Rent and office expense

 

 

26,661

 

 

38,932

 

 

83,519

 

 

104,190

 

Insurance

 

 

6,420

 

 

1,947

 

 

37,436

 

 

38,402

 

Commission

 

 

8,142

 

 

 

 

20,256

 

 

 

Other administrative expenses

 

 

6,078

 

 

6,877

 

 

13,422

 

 

12,530

 

Total costs and expenses

 

 

155,818

 

 

201,517

 

 

501,422

 

 

481,870

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(25,067

)

$

 147,358

 

$

(48,827

)

$

27,987

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share – basic and diluted

 

$

 (0.00

)

$

 0.00

 

$

(0.00

)

$

0.00

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common
shares outstanding – basic and diluted

 

 

40,076,783

 

 

30,943,450

 

 

34,637,077

 

 

30,943,450

 


See notes to financial statements



2



LESCARDEN INC.

CONDENSED STATEMENTS OF CASH FLOWS


 

 

(UNAUDITED)

For the nine months

Ended February 28,

 

 

 

2011

 

2010

 

 

     

 

 

     

 

 

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net (loss) income

 

$

(48,827

)

$

27,987

 

Adjustments to reconcile net (loss) income to net cash
used in operating activities:

 

 

 

 

 

 

 

Changes in operating assets and liabilities

 

 

 

 

 

 

 

Increase in accounts receivable

 

 

(4,709

)

 

(201,932

)

(Increase) decrease in inventory

 

 

(35,662

)

 

63,255

 

Decrease in prepaid expense

 

 

6,800

 

 

 

Increase in accounts payable and accrued expenses

 

 

26,660

 

 

80,007

 

Decrease in deferred revenue

 

 

(29,059

)

 

(2,400

)

Decrease in deferred license fees

 

 

(4,500

)

 

(83,103

)

Net cash used in operating activities

 

 

(89,297

)

 

(116,186

)

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Increase in shareholder loan

 

 

36,000

 

 

85,000

 

Cash provided by financing activities

 

 

36,000

 

 

85,000

 

 

 

 

 

 

 

 

 

Decrease in cash

 

 

(48,542

)

 

(31,186

)

 

 

 

 

 

 

 

 

Cash – beginning of period

 

 

137,928

 

 

40,265

 

 

 

 

 

 

 

 

 

Cash – end of period

 

$

84,631

 

$

9,079

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash financing activities

 

 

 

 

 

 

 

Increase in common stock resulting from loan conversion

 

 

9,134

 

 

 

Increase in paid-in capital resulting from loan conversion

 

 

264,866

 

 

 

Decrease in shareholder loan

 

 

(274,000

)

 

 


See notes to financial statements




3



LESCARDEN INC .

(UNAUDITED) NOTES TO FINANCIAL STATEMENTS

February 28, 2011

Note 1 - General:

The accompanying unaudited financial statements include all adjustments that are, in the opinion of management, necessary for a fair statement of the results for the interim periods. All such adjustments are of a normal recurring nature. The statements have been prepared in accordance with the requirements for Form 10-Q and, therefore, do not include all disclosures or financial details required by generally accepted accounting principles. These condensed financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended May 31, 2010. The results of operations for the interim periods are not necessarily indicative of results to be expected for a full year's operations.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability of assets and the satisfaction of liabilities that might be necessary should the Company be unable to continue as a going concern. As shown in the financial statements, the Company incurred a loss from operations for the nine months ended February 28, 2011, has a stockholders’ deficiency and a working capital deficiency. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.

The Company’s plan and ability to continue as a going concern is primarily dependent upon successful regulatory certification of its new packager, which will enable the Company to grow revenue through existing and new lines of business. There can be no assurance that the Company will be able to grow revenues or secure sufficient additional financing to meet future obligations.

At February 28, 2011, inventory of $112,486 consisted of $59,924 of finished goods and $52,562 of raw materials.

The Company’s assets and liabilities that qualify as financial instruments under SFAS No. 107 “Disclosures About Fair Value of Financial Instruments” (ASC 825-10-50) approximate their carrying amounts presented in the balance sheet based upon the short-term nature of the accounts at February 28, 2011.

The Company has evaluated the financial statements for subsequent events through the date of the filing of this quarterly report on Form 10-Q on April 12, 2011.



Item 2.         Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Results of Operations:

The results of operations for the nine months ended February 28, 2011 reflect increased sales volume in both Europe and Asian markets.  In anticipation of the plant closing of Amcor’s packaging facility in December 2010, the Company accelerated production and shipment of existing purchase orders from its major customers scheduled for delivery in the third fiscal quarter. The Company has selected an alternative packaging facility and anticipates its production packaging process at the new facility will be operational before the fiscal year-end.  Based on the transfer of its packaging process to Amcor in 2009, the Company expects to incur some temporary increases in cost of sales and professional fees during the third and fourth quarters associated with the set-up and calibration of the new facility and the associated regulatory recertification requirements.

Nine months ended February 28, 2011 compared to February 28, 2010

The Company’s revenues decreased 11% or $57,262 during the nine months ended February 28, 2011 compared to February 28, 2010 due to a decrease in license fee income. Total costs and expenses during the nine months ended February 28, 2011 were 4% or $19,553 higher than those of the comparative prior year



4



period due to increases in salaries $17,721 and commission expense of $20,256 offset by a decrease in rent and office expenses of $20,670.

Three months ended February 28, 2011 compared to February 28, 2010

The Company’s revenues increased in the fiscal quarter ended February 28, 2011 compared to February 28, 2010 by almost 60% or $191,923 due to a reduction in the unusually high sales of Catrix in Europe for the three months ended February 28, 2010 resulting from the fulfillment of a large backlog of orders that accumulated during a year-long production disruption, offset by a decrease in license fee income of $26,201. Total costs and expenses during the three months ended February 28, 2011 were 23% or $45,699 lower than those of the comparative prior year period. The increase was principally due to decreases in cost of sales and rent and office expense of $53,779 and $12,270, offset by increases in commission expense and salaries of $8,142 and $13,840 respectively.

Liquidity and Capital Resources

As of February 28, 2011, the Company’s current assets exceeded its accounts payable and accrued expenses e by $5,643. The Company’s cash and cash equivalents balance decreased by $53,297 in the nine months ended February 28, 2011 to $84,631. On November 10, 2011, the Company completed conversion of a $274,000 shareholder loan into common stock.  Pursuant to the Loan Conversion and Stock Purchase agreement dated November 8, 2011, the Company issued 9,133,333 shares of common stock in exchange for the extinguishment of a $274,000 shareholder loan.

The Company has no material commitments for capital expenditures at February 28, 2011.

Item 3.         Quantitative and Qualitative Disclosures About Market Risk.

Not required for smaller reporting company.

Item 4.         Controls and Procedures.

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s filings under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the periods specified in the rules and forms of the Securities and Exchange Commission. Such information is accumulated and communicated to the Company’s management, including its Chief Executive and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Company’s management, including the Chief Executive and Chief Financial Officer, recognizes that any set of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

The Company has carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on such evaluation, the Company’s Chief Executive and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this quarterly report on Form 10-Q.

There have been no significant changes in the Company’s internal controls or in other factors that could significantly affect the internal controls subsequent to the date of their evaluation in connection with the preparation of this quarterly report on Form 10-Q.



5




PART II - OTHER INFORMATION


Item 1.         Legal Proceedings.

None.

Item 1A.      Risk Factors.

None.

Item 2.         Unregistered Sales of Equity Securities and Use of Proceeds.

See Loan Conversion and Stock Purchase Agreement with Charles T. Maxwell (incorporated by reference from our Current Report on Form 8-K filed on November 10, 2010)

Item 3.         Defaults Upon Senior Securities.

None.

Item 4.         Removed and Reserved.

Item 5.         Other Information.

None.

Item 6.         Exhibits.

Exhibit No.

     

Description

31

 

Certification pursuant to Exchange Act Rule 13a – 14 (a)/15d-14(a)

32

 

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002






6



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 

LESCARDEN INC.

 

(Registrant)

                                

 

Date: April 12, 2011

 

 

 

 

 

/s/ William E. Luther

 

William E. Luther

 

Chief Executive and Chief Financial Officer

 





7